COVID-19 and mucormycosis in Latin America – An emerging concern

Thumbnail
Documento (433.3Kb)
application/pdf
Date
2021
Author(s)
Rodriguez-Morales, A.J.
Mamani-García, C.S.
Nuñez-Lupaca, J.N.
León-Figueroa, D.A.
Olarte-Durand, M.
Yrene-Cubas, R.A.
Ticona, D.M.
Abanto-Urbano, S.
Metadata
Show full item record
Abstract
During the Coronavirus Disease 2019 (COVID-19) pandemic, the improper use of corticosteroids and the presence of diabetes mellitus in patients marked the beginning of an increased incidence of fungal infections such as aspergillosis and mucormycosis in patients with this emerging viral infection. Mucormycosis is a common angioinvasive infection with significant morbidity and mortality now complicating the course of, especially severe, COVID-19. The disease spectrum comprises rhino-orbito-cerebral, pulmonary, cutaneous, gastrointestinal and disseminated mucormycosis...
URI
https://hdl.handle.net/20.500.12805/4692
DOI
https://doi.org/10.1016/j.tmaid.2021.102156
Collections
Subject
https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2